Antifungal Vfend® provides significant cost advantages when used as initial therapy

... Initial therapy with Pfizer''s antifungal treatment, VFEND® (voriconazole), IV for injection, tablets, and oral suspension, has significant cost advantages over the standard therapy, amphotericin B deoxycholate, for patients with invasive aspergillosis infections, according to a study in the June issue of Pharmacotherapy... click link for more info. ...